Skip to main content
PLUR
NASDAQ Life Sciences

EIB Defers Enforcement on $27.4M Loan, Engages in Resolution Talks Until July 3

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$2.41
Mkt Cap
$26.003M
52W Low
$2.22
52W High
$5.96
52W Position info
8.6% above low
Off High info
60% below high
Rel. Volume info
5.2× avg
Market data snapshot near publication time

PLUR is trading near its 52-week low of $2.22 (8.6% above the low) on elevated volume (5.2× avg).

Summary

Pluri Inc. received a temporary deferral from the European Investment Bank on its $27.4 million loan, with discussions for a resolution ongoing until July 3, 2026, providing a short-term reprieve from immediate default.


Key Events · Financing and Capital Events · PLUR

  • EIB Loan Maturity Update

    The European Investment Bank (EIB) has confirmed it will defer enforcement actions on Pluri's €20 million loan (approximately $27.4 million including interest), which was due on June 1, 2026.

  • Constructive Discussions Ongoing

    The EIB and Pluri Inc. are engaged in constructive discussions to explore a mutually agreed resolution, with negotiations expected to conclude by July 3, 2026.

  • Temporary Reprieve from Default

    This agreement provides Pluri Inc., which is facing an acute liquidity crisis, a temporary stay from immediate default on a significant debt obligation.


Analysis · PLUR · Life Sciences

Pluri Inc., facing an acute liquidity crisis and a significant EIB loan maturity, has secured a temporary reprieve. The EIB has agreed to defer enforcement actions and engage in constructive discussions until July 3, 2026, to find a mutually acceptable resolution. This buys the company critical time to address its financial challenges and avoid immediate default on a loan that is larger than its current market capitalization.

How filings like this one have moved

In the 30 days to Sep 11, 2026, 36.1% of the 1753 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.04%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PLUR was trading at $2.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $26M. The 52-week trading range was $2.22 to $5.96. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PLUR - Latest Insights

PLUR
Sep 10, 2026, 5:19 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.25
Real-time Price: $1.27 info
Change: +$0.020 (+2%) info
Market Cap: $15.431M info
PLUR
Aug 28, 2026, 9:21 AM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.50
Real-time Price: $1.27 info
Change: -$0.230 (-15%) info
Market Cap: $15.431M info
PLUR
Aug 28, 2026, 7:33 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.56
Real-time Price: $1.27 info
Change: -$0.290 (-19%) info
Market Cap: $15.431M info
PLUR
Aug 27, 2026, 8:03 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.47
Real-time Price: $1.27 info
Change: -$0.200 (-14%) info
Market Cap: $15.431M info
PLUR
Aug 17, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.60
Real-time Price: $1.27 info
Change: -$0.330 (-21%) info
Market Cap: $15.431M info